Mover and shaker

Houston Exponential hires serial entrepreneur and investor as president

Harvin Moore, who has a 20-year career in tech and innovation, has been named as president of Houston Exponential. Courtesy of HX

There's a new leader at the helm of the city's startup and innovation nonprofit — and he has some familiarity with the innovation ecosystem.

Harvin Moore was announced to be the new president of Houston Exponential, replacing Russ Capper, the inaugural executive director of HX. Capper has served since April 2018 and will stay involved with the organization, according to a news release.

Moore, a Houston native, has a 20-year career in tech and startups in Houston. He is a principal at an early-stage investment firm, Frontera Technology Ventures, and before that served as COO for Space Services Holdings Inc.

"We are excited to welcome someone with Harvin's track record to lead Houston Exponential through the next phase of growth in the ecosystem," says Gina Luna, chair of HX, in the release. "The Houston innovation community has made great strides in the last couple of years, and with Harvin's leadership, HX will take our work to the next level."

Moore, who was re-elected three times as Houston Independent School District's Board of Education, is described as an active advisor, mentor, and angel investor for the likes of Houston Angel Network, Capital Factory and Station Houston.

"As someone who has been involved in Houston's digital tech ecosystem since its earliest days, I am inspired by the tremendous momentum generated in just the last few years," Moore says in the release. "We are at an inflection point, and I believe Houston Exponential will continue to be a catalyst driving Houston to become a leading innovation hub within the next two to three years."

Moore joins HX at a pivotal moment as many exciting innovation projects are expected to deliver the next few years, such as MassChallenge Texas' inaugural Houston cohort, the Texas Medical Center's TMC3 campus, Rice Management Co.'s The Ion, the close of the HX Venture Fund and more.

"The pace of the wins and major announcements in our innovation space is rapidly accelerating, and I am pleased that HX has played a role in many of these, including being an enthusiastic champion for the work of many of our partners," Luna says in the release. "In this next phase of work, I expect we will continue to build valuable partnerships and will activate the venture capital firms that are showing tremendous interest in the Houston ecosystem and the startups here."

Trending News

Building Houston

 
 

Houston-based Melax Tech has developed multiple Natural language processing tools that are used by more than 650 health care and life science organizations. Photo via MelaxTech.com

Melax Tech Partners, a leader in natural language technology processing, announced a new partnership with the University of California at Irvine that will help researchers derive insights from the UCI Health Data Science Platform’s electronic health records system and improve patient care.

Melax will implement its signature text annotation tool LANN to pull information from clinical notes, and its CLAMP product to develop natural language processing customizations through the use of AI, according to a statement from the company.

“There has been a strong desire among UCI researchers to have the capability to analyze free-text clinical narrative data using cutting-edge NLP technologies," Kai Zheng, chief research information officer at UCI Health Affairs, says in a statement. "We are delighted to have this opportunity to work with Melax Tech to deploy their AI-driven annotation and analytics tools to help our researchers advance their research agenda by leveraging the vast amount of free-text data that our health system has accumulated in the past two decades.”

Natural language processing, or NLP, allows organizations and healthcare groups to sift through and analyze massive amounts of data at a rapid rate through the use of machine learning and AI. Houston-based Melax Tech, founded in 2017, has developed multiple NLP tools that are used by more than 650 health care and life science organizations, according to its website.

In addition to the recent partnership with UC Irvine, Melax has also recently partnered with Vanderbilt University Medical Center and the University of Western Pennsylvania on similar clinical projects.

Melax has also used its platforms to pull vital information from datasets relating to COVID-19, in both medical and social settings.

In March 2022, it was awarded a Phase 1 NIH Award, valued at $300,000, to develop informatics tools based on COVID-19 datasets with the San Diego Supercomputer Center at UC San Diego. The tool aims to help researchers better understand vast amounts of virus-related data and connect findings with other similar results.

In August, Melax also received another $300,000 grant from the National Institute of Allergy and Infectious Diseases to develop NLP-based algorithms that will "model, extract and synthesize vaccine misinformation from multiple popular social media sources," according to a statement. Melax will also develop a visualization that presents its findings on the misinformation into a compressible format.

"This is a very real topic affecting culture at present," Andre Pontin, CEO at Melax Tech, says in a statement. "And shows that we as a collective business and group of experts continue to be on the cutting-edge of science in the NLP and AI domain."

Trending News